VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by hassyon Apr 24, 2018 8:00pm

150 Views

Post# 27935160

RE:RE:RE:Next pp

I recall from discussion with VPT last month that the plan is allow the warrants to be excercised (at .50+? I need to look it up again), once we have this FDA approval. The amount from warrant excercise should carry us through the cash flow from the ultimate sale of the units. If all worked out as planned, which ultimately hinged on FDA approval, we may never see PP again!

Bullboard Posts

This junior mining stock offers billions in market exposure